|
Volumn 307, Issue 1, 2012, Pages 21-22
|
Researchers still seek clinical benefit in raising levels of good cholesterol
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANACETRAPIB;
CHOLESTEROL;
CHOLESTEROL ESTER TRANSFER PROTEIN;
DALCETRAPIB;
EVACETRAPIB;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
PLACEBO;
SIMVASTATIN;
TORCETRAPIB;
TRIACYLGLYCEROL;
ACUTE CORONARY SYNDROME;
CARDIOVASCULAR DISEASE;
CEREBRAL REVASCULARIZATION;
CHOLESTEROL BLOOD LEVEL;
CLINICAL RESEARCH;
DRUG EFFICACY;
ISCHEMIC HEART DISEASE;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
RISK REDUCTION;
SHORT SURVEY;
TRIACYLGLYCEROL BLOOD LEVEL;
|
EID: 84855374205
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2011.1871 Document Type: Short Survey |
Times cited : (4)
|
References (0)
|